HbA1c levels less than or equal to 5.5% ruled out, and levels greater than or equal to 7.0% ruled in, type 2 diabetes in clinical and community populations

Reeves, Leonard
August 2010
ACP Journal Club;8/17/2010, Vol. 153 Issue 2, p10
Academic Journal
The article reports on a study by Z. X. Lu and colleagues focusing on hemoglobin (Hb)A1c levels in type 2 diabetes in clinical and community populations, published in the 2010 issue of "Diabetes Care." The study revealed that HbA1c level of 5.5 percent indicated a very low probability of diabetes and 7.0 percent level indicated an extremely high probability. The results support the use of HbA1c for diagnosing and screening of diabetes.


Related Articles

  • Efficacy and Cost of Postpartum Screening Strategies for Diabetes Among Women with Histories of Gestational Diabetes. Kim, Catherine; Herman, William H.; Vijan, Sandeep // Diabetes;Jun2007 Supplement 1, Vol. 56, pA307 

    The article focuses on a study which compared the cost and time to diagnosis associated with several screening strategies for diabetes in women with histories of gestational diabetes mellitus (GDM). Simulated screening for diabetes with fasting plasma glucose (FPG), a 2-hour glucose tolerance...

  • Nurse Practitioner Management of Type 2 Diabetes. Carr Richardson, Gail; Derouin, Anne L.; Vorderstrasse, Allison A.; Hipkens, James; Thompson, Julie A. // Permanente Journal;Spring2014, Vol. 18 Issue 2, pe134 

    Context: Multifactorial barriers prevent primary care clinicians from helping their adult patients with type 2 diabetes achieve good control of hemoglobin A1c (HbA1c) levels. Patients' depression and low self-efficacy can complicate diabetes management by impairing tasks needed for effective...

  • Combined Measurement of Fasting Plasma Glucose and A1C Is Effective for the Prediction of Type 2 Diabetes. Sato, Kyoko Kogawa; Hayashi, Tomoshige; Harita, Nobuko; Yoneda, Takeshi; Nakamura, Yoshiko; Endo, Ginji; Kambe, Hiroshi // Diabetes Care;Apr2009, Vol. 32 Issue 4, p644 

    OBJECTIVE -- We prospectively assessed whether the combined measurements of fasting plasma glucose (FPG) and A1C were effective for predicting type 2 diabetes. RESEARCH DESIGN AND METHODS-- Study participants included 6,736 nondiabetic Japanese men aged 40-55 years. Type 2 diabetes was diagnosed...

  • Value of oral glucose tolerance test in the acute phase of myocardial infarction. Bronisz, Agata; Kozinski, Marek; Magielski, Przemyslaw; Fabiszak, Tomasz; Gierach, Joanna; Swiatkiewicz, Iwona; Sukiennik, Adam; Kubica, Aldona; Bronisz, Marek; Grabczewska, Zofia; Sinkiewicz, Anna; Junik, Roman; Kubica, Jacek // Cardiovascular Diabetology;2011, Vol. 10 Issue 1, p21 

    Background: Although European guidelines advise oral glucose tolerance test (OGTT) in patients with acute myocardial infarction (AMI) before or shortly after hospital discharge, data supporting this recommendation are inconclusive. We aimed to analyze whether disturbances in glucose metabolism...

  • Correlation of Glycosylated Hemoglobin and Glucose Response to Oral Glucose Tolerance Test. Kokkoris, Panagiotis; Chantziara, Clio; Toloumis, George // Diabetes;Jun2007 Supplement 1, Vol. 56, pA254 

    Glycosylated hemoglobin (HbA1c) is a reliable index of glycemic control in known diabetic patients; but its role is not very clear in riot known diabetics. The aim of the study is to find if there is any correlation between HbA1c and glucose response at the oral glucose tolerance test (OGTT) in...

  • Diabetes mellitus - Definition, Klassifikation und Diagnose. Roden, Michael // Wiener Klinische Wochenschrift;Dec2012 Supplement, Vol. 124, p1 

    Diabetes mellitus bezeichnet eine Gruppe von heterogenen Erkrankungen, deren gemeinsamer Befund die Erhöhung der Blutglukose ist. Die gegenwärtigen Klassifikationen von Diabetes mellitus Typ 1-4 werden beschrieben und die wesentlichen Merkmale von Typ 1 und Typ 2 Diabetes werden zur...

  • Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. K M Goode // Heart;Jun2009, Vol. 95 Issue 11, p917 

    BACKGROUND: Glycated haemoglobin (HbA1c) is an indicator of average blood glucose concentrations over the preceding 3 months, is simpler to perform than either a fasting glucose or glucose tolerance test and is associated with a worse prognosis in some clinical settings. However, its...

  • Hemoglobin A1c as a Diagnostic Tool for Diabetes Screening and New-Onset Diabetes Prediction. SUNG HEE CHOI; TAE HYUK KIM; SOO LIM; KYONG SOO PARK; JANG, HAK C.; CHO, NAM H. // Diabetes Care;Apr2011, Vol. 34 Issue 4, p944 

    OBJECTIVE--Various cutoff levels of hemoglobin A1c (A1C) have been suggested to screen for diabetes, although more consensus about the best level, especially for different ethnicities, is required. We evaluated the usefulness of A1C levels when screening for undiagnosed diabetes and as a...

  • The Cut-Off Value of Hba1c to Define the Prediabetic Stage in High-Risk Patients. Soo-Kyung Kim; Seok-Won Park; Yong-Wook Cho // Diabetes;Jun2007 Supplement 1, Vol. 56, pA626 

    Background; Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are very important risk factors to suggest the progression of overt diabetes and the development of cardiovascular disease. However, oral glucose tolerance test (OGTT) able to define the IGT is time-consuming and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics